Executive Vice President and Chief HR Officer Danielle L. Kirgan executed a sale of 3,047 shares of Macy's common stock on March 25, 2026, generating approximately $57,031 in proceeds. The disposals were completed at a weighted average price of $18.7173 per share, with the individual sale prices ranging from $18.685 to $18.76.
Kirgan had converted restricted stock units into common stock one day earlier. On March 24 she exercised 8,539 restricted stock units, which converted into shares of common stock.
Following the March 24 exercise and the March 25 sale, Kirgan's direct ownership of Macy's common stock stands at 56,653 shares.
At the time of the transactions, Macy's stock was trading at $18.49, with a market capitalization of $4.84 billion. Over the past year the shares have delivered a total return of 45.8%.
Valuation metrics shown for the retailer include a price-to-earnings ratio of 7.92. According to InvestingPro, Macy's is trading at a low earnings multiple relative to near-term growth - a detail listed as one of 12 exclusive ProTips available to subscribers. For investors seeking further analysis, Macy's comprehensive Pro Research Report is available through InvestingPro for this company and more than 1,400 other US equities.
Separately, Macy's reported fourth-quarter 2025 financial results that outpaced consensus expectations. The company posted earnings per share of $1.67, above analysts' estimates of $1.56. Revenue for the quarter came in at $7.6 billion, exceeding the projected $7.46 billion. Same-store sales increased 1.8%, with strength attributed to fragrance and luxury categories.
Despite the quarter's upside, several sell-side firms revised their outlooks on Macy's stock. TD Cowen lowered its price target to $20 from $21 and maintained a Hold rating. Telsey reduced its target to $20 from $25, citing macroeconomic uncertainty and keeping a Market Perform rating. Evercore ISI trimmed its target to $19 from $21 due to valuation concerns and kept an In Line rating. Jefferies reiterated a Buy rating with a $22 price target, acknowledging the company’s fourth-quarter performance while noting that initial fiscal 2026 guidance came in below Wall Street estimates.
The transactions by Kirgan and the mixed analyst responses follow a quarter that beat expectations on both the top and bottom lines, while valuation and forward guidance remain topics of debate among analysts.